These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8758257)

  • 21. AZT: a biochemical response modifier of methotrexate and 5-fluorouracil cytotoxicity in human ovarian and pancreatic carcinoma cells.
    Weber G; Nagai M; Prajda N; Nakamura H; Szekeres T; Olah E
    Cancer Commun; 1991 Apr; 3(4):127-32. PubMed ID: 2025497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous azidothymidine with fluorouracil and leucovorin: a phase I-II study in previously untreated metastatic colorectal cancer patients.
    Falcone A; Danesi R; Dargenio F; Pfanner E; Brunetti I; Del Tacca M; Nethersell AB; Conte PF
    J Clin Oncol; 1996 Mar; 14(3):729-36. PubMed ID: 8622018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. UCN-01 (7-hydroxystaurosporine) enhances 5-fluorouracil cytotoxicity through down-regulation of thymidylate synthetase messenger RNA.
    Abe S; Kubota T; Otani Y; Furukawa T; Watanabe M; Kumai K; Kitajima M
    Jpn J Cancer Res; 2000 Nov; 91(11):1192-8. PubMed ID: 11092986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison between CoFactor and Leucovorin activity applied in combination with 5-fluorouracil against two human colon cancer cell lines.
    Bjelogrlić SK; Srdić T; Radulović S
    J BUON; 2007; 12(1):71-6. PubMed ID: 17436405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Azidothymidine inhibition of thymidine kinase and synergistic cytotoxicity with methotrexate and 5-fluorouracil in rat hepatoma and human colon cancer cells.
    Weber G; Ichikawa S; Nagai M; Natsumeda Y
    Cancer Commun; 1990; 2(4):129-33. PubMed ID: 2369552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The synergistic and antagonistic effects of cytotoxic and biological agents on the in vitro antitumour effects of suramin.
    Lopez Lopez R; van Rijswijk RE; Wagstaff J; Pinedo HM; Peters GJ
    Eur J Cancer; 1994; 30A(10):1545-9. PubMed ID: 7833116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Search for the optimal schedule for the oxaliplatin/5-fluorouracil association modulated or not by folinic acid: preclinical data.
    Fischel JL; Etienne MC; Formento P; Milano G
    Clin Cancer Res; 1998 Oct; 4(10):2529-35. PubMed ID: 9796987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic cytotoxicity of AZT plus alpha and gamma interferon in chronic myeloid leukemia cell line K562.
    Tosi P; Visani G; Ottaviani E; Gamberi B; Cenacchi A; Tura S
    Eur J Haematol; 1993 Oct; 51(4):209-13. PubMed ID: 8243609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tenacissoside G synergistically potentiates inhibitory effects of 5-fluorouracil to human colorectal cancer.
    Wang K; Liu W; Xu Q; Gu C; Hu D
    Phytomedicine; 2021 Jun; 86():153553. PubMed ID: 33906076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cytotoxic effects of the combination of a new nitrosourea, fotemustine, combined with 5-fluorouracil and folinic acid depend on the sequence of their administration].
    Fischel JL; Formento P; Berlion M; Berille J; Gioanni J; Bizzari JP; Milano G
    Bull Cancer; 1992; 79(1):81-90. PubMed ID: 1520955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Schedule-dependent interaction between raltitrexed and 5-fluorouracil in human colon cancer cell lines in vitro.
    Kano Y; Akutsu M; Suzuki K; Yazawa Y; Tsunoda S; Furukawa Y
    Oncol Res; 2000; 12(3):137-48. PubMed ID: 11216672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistically Anti-metastatic Effect of 5-Flourouracil on Colorectal Cancer Cells via Calcium-mediated Focal Adhesion Kinase Proteolysis.
    Park M; Sundaramoorthy P; Sim JJ; Jeong KY; Kim HM
    Anticancer Res; 2017 Jan; 37(1):103-114. PubMed ID: 28011480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipoic acid induces p53-independent cell death in colorectal cancer cells and potentiates the cytotoxicity of 5-fluorouracil.
    Dörsam B; Göder A; Seiwert N; Kaina B; Fahrer J
    Arch Toxicol; 2015 Oct; 89(10):1829-46. PubMed ID: 25526924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potentiation of the sensitivity of renal cell carcinoma cells to TRAIL-mediated apoptosis by subtoxic concentrations of 5-fluorouracil.
    Mizutani Y; Nakanishi H; Yoshida O; Fukushima M; Bonavida B; Miki T
    Eur J Cancer; 2002 Jan; 38(1):167-76. PubMed ID: 11750847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gypenosides Synergistically Enhances the Anti-Tumor Effect of 5-Fluorouracil on Colorectal Cancer In Vitro and In Vivo: A Role for Oxidative Stress-Mediated DNA Damage and p53 Activation.
    Kong L; Wang X; Zhang K; Yuan W; Yang Q; Fan J; Wang P; Liu Q
    PLoS One; 2015; 10(9):e0137888. PubMed ID: 26368019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synchronization of cells in the S phase of the cell cycle by 3'-azido-3'-deoxythymidine: implications for cell cytotoxicity.
    Chandrasekaran B; Kute TE; Duch DS
    Cancer Chemother Pharmacol; 1995; 35(6):489-95. PubMed ID: 7882457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergism and lack of cross-resistance between short-term and continuous exposure to fluorouracil in human colon adenocarcinoma cells.
    Sobrero AF; Aschele C; Guglielmi AP; Mori AM; Melioli GG; Rosso R; Bertino JR
    J Natl Cancer Inst; 1993 Dec; 85(23):1937-44. PubMed ID: 8230285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ICI D1694 and idoxuridine: a synergistic antitumor combination.
    Pressacco J; Hedley DW; Erlichman C
    Cancer Res; 1994 Jul; 54(14):3772-8. PubMed ID: 8033097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pretreatment with 5-fluorouracil enhances cytotoxicity and retention of DNA-bound platinum in a cisplatin resistant human ovarian cancer cell line.
    Tanaka T; Masuda H; Naito M; Tamai H
    Anticancer Res; 2001; 21(4A):2463-9. PubMed ID: 11724308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequence-dependent growth inhibition and DNA damage formation by the irinotecan-5-fluorouracil combination in human colon carcinoma cell lines.
    Mans DR; Grivicich I; Peters GJ; Schwartsmann G
    Eur J Cancer; 1999 Dec; 35(13):1851-61. PubMed ID: 10674003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.